-
1
-
-
0023242424
-
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
-
Allegra, C. J., B. A. Chabner, C. U. Tuazon, D. Ogata-Arakaki, B. Baird, J. C. Drake, T. Simmons, E. E. Lack, J. H. Shelhamer, F. Balis, R. Walker, J. A. Kovacs, H. C. Lane, and H. Masur. 1987. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 317:978-985.
-
(1987)
N. Engl. J. Med.
, vol.317
, pp. 978-985
-
-
Allegra, C.J.1
Chabner, B.A.2
Tuazon, C.U.3
Ogata-Arakaki, D.4
Baird, B.5
Drake, J.C.6
Simmons, T.7
Lack, E.E.8
Shelhamer, J.H.9
Balis, F.10
Walker, R.11
Kovacs, J.A.12
Lane, H.C.13
Masur, H.14
-
2
-
-
0026575017
-
Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide
-
Balkovac, J. M., R. M. Black, M. L. Hammond, J. V. Heck, R. A. Zambias, G. Abruzzo, K. Bartizal, H. Kropp, C. Trainor, R. E. Schwartz, D. C. McFadden, K. H. Nollstadt, L. A. Pittarelli, M. A. Powles, and D. M. Schmatz. 1992. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. J. Med. Chem. 35:194-198.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 194-198
-
-
Balkovac, J.M.1
Black, R.M.2
Hammond, M.L.3
Heck, J.V.4
Zambias, R.A.5
Abruzzo, G.6
Bartizal, K.7
Kropp, H.8
Trainor, C.9
Schwartz, R.E.10
McFadden, D.C.11
Nollstadt, K.H.12
Pittarelli, L.A.13
Powles, M.A.14
Schmatz, D.M.15
-
3
-
-
19244363256
-
Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia
-
Barber, B. A., P. S. Pegram, and K. P. High. 1996. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 23: 718-722.
-
(1996)
Clin. Infect. Dis.
, vol.23
, pp. 718-722
-
-
Barber, B.A.1
Pegram, P.S.2
High, K.P.3
-
4
-
-
0028061291
-
Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice
-
Bartlett, M., T. Edlind, C. Lee, R. Dean, S. Queener, M. Shaw, and J. Smith. 1994. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob. Agents Chemother. 38:1834-1837.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 1834-1837
-
-
Bartlett, M.1
Edlind, T.2
Lee, C.3
Dean, R.4
Queener, S.5
Shaw, M.6
Smith, J.7
-
5
-
-
0028851780
-
Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii
-
Bartlett, M. S., M. M. Shaw, P. Navaran, J. W. Smith, and S. F. Queener. 1995. Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrob. Agents Chemother. 39:2436-2441.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 2436-2441
-
-
Bartlett, M.S.1
Shaw, M.M.2
Navaran, P.3
Smith, J.W.4
Queener, S.F.5
-
6
-
-
0026598457
-
Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii
-
Bartlett, M. S., T. D. Edlind, M. M. Durkin, M. M. Shaw, S. F. Queener, and J. W. Smith. 1992. Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii. Antimicrob. Agents Chemother. 36:779-782.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 779-782
-
-
Bartlett, M.S.1
Edlind, T.D.2
Durkin, M.M.3
Shaw, M.M.4
Queener, S.F.5
Smith, J.W.6
-
7
-
-
0026072156
-
Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon
-
Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859-3862.
-
(1991)
Infect. Immun.
, vol.59
, pp. 3859-3862
-
-
Beck, J.M.1
Liggitt, H.D.2
Brunette, E.N.3
Fuchs, H.J.4
Shellito, J.E.5
Debs, R.J.6
-
8
-
-
0028348331
-
Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS
-
Bernstein, B., P. Flomenberg, and D. Letzer. 1987. Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS. South. Med. J. 87:537-538.
-
(1987)
South. Med. J.
, vol.87
, pp. 537-538
-
-
Bernstein, B.1
Flomenberg, P.2
Letzer, D.3
-
9
-
-
0028335216
-
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS (ACTG 044)
-
Black, J. R., J. Feinberg, R. L. Murphy, R. J. Fass, D. Finkelstein, and B. Akil. 1994. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS (ACTG 044). Clin. Infect. Dis. 18:905-913.
-
(1994)
Clin. Infect. Dis.
, vol.18
, pp. 905-913
-
-
Black, J.R.1
Feinberg, J.2
Murphy, R.L.3
Fass, R.J.4
Finkelstein, D.5
Akil, B.6
-
10
-
-
0028956777
-
Dicationic diarylfurans and anti-Pneumocystis carinii agents
-
Boykin, D. W., A. Kumar, J. Spychala, M. Zhou, R. J. Lombardy, W. D. Wilson, C. C. Dykstra, S. K. Jones, J. E. Hall, R. R. Tidwell, C. Laughton, C. M. Nunn, and S. Neidle. 1995. Dicationic diarylfurans and anti-Pneumocystis carinii agents. J. Med. Chem. 38:912-916.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 912-916
-
-
Boykin, D.W.1
Kumar, A.2
Spychala, J.3
Zhou, M.4
Lombardy, R.J.5
Wilson, W.D.6
Dykstra, C.C.7
Jones, S.K.8
Hall, J.E.9
Tidwell, R.R.10
Laughton, C.11
Nunn, C.M.12
Neidle, S.13
-
11
-
-
0028920743
-
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection
-
Bozzette, S. A., D. M. Finkelstein, S. A. Spector, P. Frame, W. G. Powderly, W. He, L. Phillips, D. Craven, C. Van der Horst, J. Feinberg, and NIAID AIDS Clinical Trials Group. 1995. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332:693-699.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 693-699
-
-
Bozzette, S.A.1
Finkelstein, D.M.2
Spector, S.A.3
Frame, P.4
Powderly, W.G.5
He, W.6
Phillips, L.7
Craven, D.8
Van Der Horst, C.9
Feinberg, J.10
-
12
-
-
0025153147
-
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
-
Bozzette, S. A., F. R. Sattler, J. Chiu, A. W. Wu, D. Gluckstein, C. Kemper, A. Bartok, J. Niosi, I. Abramson, J. Coffman, C. Hugghlett, R. Loya, B. Cassens, B. Akil, T. Meng, C. T. Boylen, D. Nielsen, D. D. Richman, J. G. Tilles, J. Leedom, J. A. McCutchan, and California Collaborative Treatment Group. 1990. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:1451-1457.
-
(1990)
N. Engl. J. Med.
, vol.323
, pp. 1451-1457
-
-
Bozzette, S.A.1
Sattler, F.R.2
Chiu, J.3
Wu, A.W.4
Gluckstein, D.5
Kemper, C.6
Bartok, A.7
Niosi, J.8
Abramson, I.9
Coffman, J.10
Hugghlett, C.11
Loya, R.12
Cassens, B.13
Akil, B.14
Meng, T.15
Boylen, C.T.16
Nielsen, D.17
Richman, D.D.18
Tilles, J.G.19
Leedom, J.20
McCutchan, J.A.21
more..
-
13
-
-
0028204471
-
Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia
-
Caumes, E., C. Roudier, O. Rogeaux, F. Bricaire, and M. Gentilini. 1994. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clin. Infect. Dis. 18:319-323.
-
(1994)
Clin. Infect. Dis.
, vol.18
, pp. 319-323
-
-
Caumes, E.1
Roudier, C.2
Rogeaux, O.3
Bricaire, F.4
Gentilini, M.5
-
14
-
-
0029562294
-
Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus
-
Conte, J. E., Jr., and J. A. Golden. 1995. Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. J. Clin. Pharmacol. 35:1166-1173.
-
(1995)
J. Clin. Pharmacol.
, vol.35
, pp. 1166-1173
-
-
Conte J.E., Jr.1
Golden, J.A.2
-
15
-
-
0025293183
-
Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial
-
Conte, J. E., Jr., D. Chernoff, D. W. Feigal, Jr., P. Joseph, C. McDonald, and J. A. Golden. 1990. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann. Intern. Med. 113:203-209.
-
(1990)
Ann. Intern. Med.
, vol.113
, pp. 203-209
-
-
Conte J.E., Jr.1
Chernoff, D.2
Feigal D.W., Jr.3
Joseph, P.4
McDonald, C.5
Golden, J.A.6
-
16
-
-
0029975414
-
Employment of terbinafine against Pneumocystis carinii infection in rat models
-
Contini, C., D. Colombo, R. Cultrera, E. Prini, T. Sechi, E. Angelici, and R. Canipari. 1996. Employment of terbinafine against Pneumocystis carinii infection in rat models. Br. J. Dermatol. 46:30-32.
-
(1996)
Br. J. Dermatol.
, vol.46
, pp. 30-32
-
-
Contini, C.1
Colombo, D.2
Cultrera, R.3
Prini, E.4
Sechi, T.5
Angelici, E.6
Canipari, R.7
-
17
-
-
0028607228
-
Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia
-
Contini, C., M. Manganaro, R. Romani, S. Tzantzoglou, I. Poggesi, I. Vullo, V. S. Delia, and C. DeSimone. 1994. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia. J. Antimicrob. Chemother. 34:727-735.
-
(1994)
J. Antimicrob. Chemother.
, vol.34
, pp. 727-735
-
-
Contini, C.1
Manganaro, M.2
Romani, R.3
Tzantzoglou, S.4
Poggesi, I.5
Vullo, I.6
Delia, V.S.7
DeSimone, C.8
-
18
-
-
0028025544
-
Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of mammalian cells
-
Dykstra, C. C., D. R. McClernon, L. P. Elwell, and R. R. Tidwell. 1994. Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of mammalian cells. Antimicrob. Agents Chemother. 38:1890-1898.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 1890-1898
-
-
Dykstra, C.C.1
McClernon, D.R.2
Elwell, L.P.3
Tidwell, R.R.4
-
19
-
-
0029652322
-
Case records of the Massachusetts General Hospital
-
Fishman, J. A. 1995. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 332:249-258.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 249-258
-
-
Fishman, J.A.1
-
20
-
-
0031959697
-
Prevention of infection due to Pneumocystis carinii
-
19a. Fishman, J. A. 1998. Prevention of infection due to Pneumocystis carinii. Antimicrob. Agents Chemother. 42:995-1004.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 995-1004
-
-
Fishman, J.A.1
-
21
-
-
0027235455
-
Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model
-
Fishman, J. A., S. F. Queener, R. S. Roth, and M. S. Bartlett. 1993. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob. Agents Chemother. 37:1543-1546.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 1543-1546
-
-
Fishman, J.A.1
Queener, S.F.2
Roth, R.S.3
Bartlett, M.S.4
-
22
-
-
0025144705
-
Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A double blind, placebo controlled trial
-
Gagnon, S., A. M. Boota, M. A. Fischl, H. Baier, O. W. Kirksey, and L. LaVoie. 1990. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double blind, placebo controlled trial. N. Engl. J. Med. 323:1444-1450.
-
(1990)
N. Engl. J. Med.
, vol.323
, pp. 1444-1450
-
-
Gagnon, S.1
Boota, A.M.2
Fischl, M.A.3
Baier, H.4
Kirksey, O.W.5
Lavoie, L.6
-
23
-
-
0030899403
-
Neutralization of interferon-gamma exacerbates pneumocystis driven interstitial pneumonitis following bone marrow transplantation in mice
-
Garvy, B. A., F. Gigliotti, and A. G. Harmsen. 1997. Neutralization of interferon-gamma exacerbates pneumocystis driven interstitial pneumonitis following bone marrow transplantation in mice. J. Clin. Invest. 99:1637-1644.
-
(1997)
J. Clin. Invest.
, vol.99
, pp. 1637-1644
-
-
Garvy, B.A.1
Gigliotti, F.2
Harmsen, A.G.3
-
24
-
-
0026729844
-
Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia
-
Hoffman, A., M. Lawrence, F. Ognibene, A. Suffredini, G. Lipschik, J. Kovacs, H. Masur, and J. Shelhamer. 1992. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest 102:1730-1736.
-
(1992)
Chest
, vol.102
, pp. 1730-1736
-
-
Hoffman, A.1
Lawrence, M.2
Ognibene, F.3
Suffredini, A.4
Lipschik, G.5
Kovacs, J.6
Masur, H.7
Shelhamer, J.8
-
25
-
-
0027178290
-
Anti-Pneumocystis carinii activity of PS-15, a new higuanide folate antagonist
-
Hughes, W., D. Jacobus, C. Canfield, and J. Killmar. 1993. Anti-Pneumocystis carinii activity of PS-15, a new higuanide folate antagonist. Antimicrob. Agents Chemother. 37:1417-1419.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 1417-1419
-
-
Hughes, W.1
Jacobus, D.2
Canfield, C.3
Killmar, J.4
-
26
-
-
0029868005
-
Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia
-
Hughes, W., and J. Killmar. 1996. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 40:962-965.
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 962-965
-
-
Hughes, W.1
Killmar, J.2
-
27
-
-
0028040787
-
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model
-
Hughes, W., J. Killmar, and H. Oz. 1994. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model. J. Infect. Dis. 170: 906-911.
-
(1994)
J. Infect. Dis.
, vol.170
, pp. 906-911
-
-
Hughes, W.1
Killmar, J.2
Oz, H.3
-
28
-
-
0027288589
-
Comparison of atovaquone (566c80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS
-
Hughes, W., G. Leoung, F. Kramer, S. A. Bozzette, S. Safrin, P. Frame, N. Clumeck, H. Masur, D. Lancaster, C. Chan, J. Lavelle, J. Rosenstock, J. Falloon, J. Feinberg, S. LaFon, M. Rogers, and F. Sattler. 1993. Comparison of atovaquone (566c80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med. 328: 1521-1527.
-
(1993)
N. Engl. J. Med.
, vol.328
, pp. 1521-1527
-
-
Hughes, W.1
Leoung, G.2
Kramer, F.3
Bozzette, S.A.4
Safrin, S.5
Frame, P.6
Clumeck, N.7
Masur, H.8
Lancaster, D.9
Chan, C.10
Lavelle, J.11
Rosenstock, J.12
Falloon, J.13
Feinberg, J.14
LaFon, S.15
Rogers, M.16
Sattler, F.17
-
29
-
-
0017834176
-
Comparison of pentamidine isethionate and trimethoprimsulfamethoxazole in the treatment of Pneumocystis carinii pneumonia
-
Hughes, W. T., S. Feldman, S. C. Chaudhary, M. J. Ossi, F. Cox, and S. K. Sanyal. 1978. Comparison of pentamidine isethionate and trimethoprimsulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J. Pediatr. 92:285-291.
-
(1978)
J. Pediatr.
, vol.92
, pp. 285-291
-
-
Hughes, W.T.1
Feldman, S.2
Chaudhary, S.C.3
Ossi, M.J.4
Cox, F.5
Sanyal, S.K.6
-
30
-
-
0028957202
-
Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia
-
Hughes, W. T., S. LaFon, J. Scott, and H. Masur. 1995. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Infect. Dis. 171:1295-1301.
-
(1995)
J. Infect. Dis.
, vol.171
, pp. 1295-1301
-
-
Hughes, W.T.1
LaFon, S.2
Scott, J.3
Masur, H.4
-
31
-
-
0028785517
-
Monitoring of co-trimoxazole concentrations in serum during treatment of Pneumocystis carinii pneumonia
-
Joos, B., J. Blaser, M. Opravil, J. P. Chave, and R. Luthy. 1995. Monitoring of co-trimoxazole concentrations in serum during treatment of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 39:2661-2666.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 2661-2666
-
-
Joos, B.1
Blaser, J.2
Opravil, M.3
Chave, J.P.4
Luthy, R.5
-
32
-
-
0028009940
-
Human immunodeficiency virus type I infection of human macrophages modulates the cytokine response to Pneumocystis carinii
-
Kandil, O., J. A. Fishman, H. Koziel, P. Pinkston, R. M. Rose, and H. G. Remold. 1994. Human immunodeficiency virus type I infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62:644-650.
-
(1994)
Infect. Immun.
, vol.62
, pp. 644-650
-
-
Kandil, O.1
Fishman, J.A.2
Koziel, H.3
Pinkston, P.4
Rose, R.M.5
Remold, H.G.6
-
33
-
-
0025373992
-
Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS
-
Kay, R., and R. E. DuBois. 1990. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. South. Med. J. 83:403-404.
-
(1990)
South. Med. J.
, vol.83
, pp. 403-404
-
-
Kay, R.1
DuBois, R.E.2
-
34
-
-
0023257498
-
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii
-
Kovacs, J., C. Allegra, B. Chabner, J. Swan, J. Drake, M. Lunde, J. Parrillo, and H. Masur. 1987. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii. J. Infect. Dis. 155:1027-1032.
-
(1987)
J. Infect. Dis.
, vol.155
, pp. 1027-1032
-
-
Kovacs, J.1
Allegra, C.2
Chabner, B.3
Swan, J.4
Drake, J.5
Lunde, M.6
Parrillo, J.7
Masur, H.8
-
35
-
-
0022652831
-
Dapsonetrimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
-
Leoung, G., J. Mills, P. Hopewell, W. Hughes, and C. Wofsy. 1986. Dapsonetrimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:45-48.
-
(1986)
Ann. Intern. Med.
, vol.105
, pp. 45-48
-
-
Leoung, G.1
Mills, J.2
Hopewell, P.3
Hughes, W.4
Wofsy, C.5
-
36
-
-
0025991669
-
Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus
-
Levine, S. J., H. Masur, V. J. Gill, I. Feuerstein, A. F. Suffredini, D. Brown, H. C. Lane, R. Yarchoan, J. H. Shelhamer, and F. P. Ognibene. 1991. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am. Rev. Respir. Dis. 144:760-764.
-
(1991)
Am. Rev. Respir. Dis.
, vol.144
, pp. 760-764
-
-
Levine, S.J.1
Masur, H.2
Gill, V.J.3
Feuerstein, I.4
Suffredini, A.F.5
Brown, D.6
Lane, H.C.7
Yarchoan, R.8
Shelhamer, J.H.9
Ognibene, F.P.10
-
37
-
-
0029153566
-
Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia
-
Martos, A., D. Podzamczer, J. Martinez Lacasa, G. Rufi, M. Santin, and F. Gudiol. 1995. Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia. AIDS 9:1037-1041.
-
(1995)
AIDS
, vol.9
, pp. 1037-1041
-
-
Martos, A.1
Podzamczer, D.2
Martinez Lacasa, J.3
Rufi, G.4
Santin, M.5
Gudiol, F.6
-
38
-
-
0029077598
-
Effect of corticosteroids on survival of children with acquired
-
McLaughlin, G. E., S. S. Virdee, C. L. Schleien, B. H. Holzman, and G. B. Scott. 1995. Effect of corticosteroids on survival of children with acquired. J. Pediatr. 126:821-824.
-
(1995)
J. Pediatr.
, vol.126
, pp. 821-824
-
-
McLaughlin, G.E.1
Virdee, S.S.2
Schleien, C.L.3
Holzman, B.H.4
Scott, G.B.5
-
39
-
-
0029868424
-
Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor
-
Merali, S., and A. Clarkson. 1996. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor. Antimicrob. Agents Chemother. 40:973-978.
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 973-978
-
-
Merali, S.1
Clarkson, A.2
-
40
-
-
0025324166
-
Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)
-
Montaner, J. S. G., L. M. Lawson, N. Levitt, A. Belzberg, M. T. Schecter, and J. Ruedy. 1990. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 113:14-20.
-
(1990)
Ann. Intern. Med.
, vol.113
, pp. 14-20
-
-
Montaner, J.S.G.1
Lawson, L.M.2
Levitt, N.3
Belzberg, A.4
Schecter, M.T.5
Ruedy, J.6
-
41
-
-
0027989925
-
Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii
-
Morris, S. A., R. E. Schwartz, D. F. Sesin, P. Masurekar, T. C. Hallada, D. M. Schmatz, K. Bartial, O. D. Hensens, and D. L. Zink. 1994. Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii. J. Antibiot. 47:755-764.
-
(1994)
J. Antibiot.
, vol.47
, pp. 755-764
-
-
Morris, S.A.1
Schwartz, R.E.2
Sesin, D.F.3
Masurekar, P.4
Hallada, T.C.5
Schmatz, D.M.6
Bartial, K.7
Hensens, O.D.8
Zink, D.L.9
-
42
-
-
0026601038
-
Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia
-
Noskin, G., R. Murphy, J. Black, and F. Phair. 1992. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin. Intect. Dis. 14:183-188.
-
(1992)
Clin. Intect. Dis.
, vol.14
, pp. 183-188
-
-
Noskin, G.1
Murphy, R.2
Black, J.3
Phair, F.4
-
43
-
-
0031000844
-
A 5-year retrospective review of adverse drug reactions and their risk factors in HIV-infected patients who were receiving intravenous therapy for Pneumocystis carinii pneumonia
-
O'Brien, J. G., B. J. Dong, R. L. Coleman, L. Gee, and K. B. Balano. 1997. A 5-year retrospective review of adverse drug reactions and their risk factors in HIV-infected patients who were receiving intravenous therapy for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 24:854-859.
-
(1997)
Clin. Infect. Dis.
, vol.24
, pp. 854-859
-
-
O'Brien, J.G.1
Dong, B.J.2
Coleman, R.L.3
Gee, L.4
Balano, K.B.5
-
44
-
-
0029887803
-
Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat
-
Phelps, D., T. Umstead, R. Rose, and J. A. Fishman. 1996. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat. Eur. Respir. J. 9:565-570.
-
(1996)
Eur. Respir. J.
, vol.9
, pp. 565-570
-
-
Phelps, D.1
Umstead, T.2
Rose, R.3
Fishman, J.A.4
-
45
-
-
0027491678
-
8-Aminoquinolines effective against Pneumocystis carinii in vitro and in vivo
-
Queener, S., M. Bartlett, M. Nasr, and J. Smith. 1993. 8-Aminoquinolines effective against Pneumocystis carinii in vitro and in vivo. Antimicrob. Agents Chemother. 37:2166-2172.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 2166-2172
-
-
Queener, S.1
Bartlett, M.2
Nasr, M.3
Smith, J.4
-
46
-
-
0025203459
-
Extrapulmonary pneumocystosis: The first 50 cases
-
Raviglione, M. C. 1990. Extrapulmonary pneumocystosis: the first 50 cases. Rev. Infect. Dis. 12:1127-1138.
-
(1990)
Rev. Infect. Dis.
, vol.12
, pp. 1127-1138
-
-
Raviglione, M.C.1
-
47
-
-
0027439404
-
Studies on the effects of several pentamidine analogues on the NMDA receptor
-
Reynolds, I. J., D. M. Zeleski, K. D. Rothermund, K. A. Hartnett, R. R. Tidwell, and E. Aizenman. 1993. Studies on the effects of several pentamidine analogues on the NMDA receptor. Eur. J. Pharmacol. 244:175-179.
-
(1993)
Eur. J. Pharmacol.
, vol.244
, pp. 175-179
-
-
Reynolds, I.J.1
Zeleski, D.M.2
Rothermund, K.D.3
Hartnett, K.A.4
Tidwell, R.R.5
Aizenman, E.6
-
48
-
-
0027286013
-
Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients
-
Ruf, B., D. Schurmann, F. Bergmann, W. Schuler Maue, T. Grunewald, W. Gottschalk, H. Witt, and H. D. Pohle. 1993. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 12:325-329.
-
(1993)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.12
, pp. 325-329
-
-
Ruf, B.1
Schurmann, D.2
Bergmann, F.3
Schuler Maue, W.4
Grunewald, T.5
Gottschalk, W.6
Witt, H.7
Pohle, H.D.8
-
49
-
-
0030005029
-
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS
-
Safrin, S., D. Finkelstein, J. Feinberg, P. Frame, G. Simpson, A. Wu, T. Cheung, R. Soeiro, P. Hojczyk, and J. R. Black. 1996. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann. Intern. Med. 124:792-802.
-
(1996)
Ann. Intern. Med.
, vol.124
, pp. 792-802
-
-
Safrin, S.1
Finkelstein, D.2
Feinberg, J.3
Frame, P.4
Simpson, G.5
Wu, A.6
Cheung, T.7
Soeiro, R.8
Hojczyk, P.9
Black, J.R.10
-
50
-
-
0027932751
-
Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death
-
Safrin, S., B. Lee, and M. Sande. 1994. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J. Infect. Dis. 170:912-917.
-
(1994)
J. Infect. Dis.
, vol.170
, pp. 912-917
-
-
Safrin, S.1
Lee, B.2
Sande, M.3
-
51
-
-
0027971603
-
Ornithine decarboxylase in Pneumocystis carinii and implications for therapy
-
Saric, M., and A. Clarkson. 1994. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy. Antimicrob. Agents Chemother. 38: 2545-2552.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2545-2552
-
-
Saric, M.1
Clarkson, A.2
-
52
-
-
0028364088
-
Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: A prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031
-
Sattler, F., and ACTG 029/031. 1994. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031. J. Infect. Dis. 170:165-172.
-
(1994)
J. Infect. Dis.
, vol.170
, pp. 165-172
-
-
Sattler, F.1
-
53
-
-
0023755203
-
Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A prospective, noncrossover study
-
Sattler, F. R., R. Cowan, D. M. Nielsen, and J. Ruskin. 1988. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, noncrossover study. Ann. Intern. Med. 109:280-287.
-
(1988)
Ann. Intern. Med.
, vol.109
, pp. 280-287
-
-
Sattler, F.R.1
Cowan, R.2
Nielsen, D.M.3
Ruskin, J.4
-
54
-
-
0029088797
-
Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus
-
Simonds, R., W. Hughes, J. Feinberg, and T. Navin. 1995. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl. 1):S44-S48.
-
(1995)
Clin. Infect. Dis.
, vol.21
, Issue.1 SUPPL.
-
-
Simonds, R.1
Hughes, W.2
Feinberg, J.3
Navin, T.4
-
55
-
-
0027236690
-
Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia
-
Tidwell, R. R., S. K. Jones, N. A. Naiman, L. C. Berger, W. B. Brake, C. C. Dykstra, and J. E. Hall. 1993. Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 37:1713-1716.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 1713-1716
-
-
Tidwell, R.R.1
Jones, S.K.2
Naiman, N.A.3
Berger, L.C.4
Brake, W.B.5
Dykstra, C.C.6
Hall, J.E.7
-
56
-
-
0027248912
-
Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: A randomized, double blind pilot trial
-
Toma, E., S. Fournier, M. Dumont, P. Bolduc, and H. Deschamps. 1993. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double blind pilot trial. Clin. Infect. Dis. 17:178-184.
-
(1993)
Clin. Infect. Dis.
, vol.17
, pp. 178-184
-
-
Toma, E.1
Fournier, S.2
Dumont, M.3
Bolduc, P.4
Deschamps, H.5
-
57
-
-
0024604644
-
Clindamycin with primaquine for Pneumocystis carinii pneumonia
-
Toma, E., S. Fournier, M. Poisson, R. Morisset, D. Phaneuf, and C. Vega. 1989. Clindamycin with primaquine for Pneumocystis carinii pneumonia. Lancet i:1046-1048.
-
(1989)
Lancet
, vol.1
, pp. 1046-1048
-
-
Toma, E.1
Fournier, S.2
Poisson, M.3
Morisset, R.4
Phaneuf, D.5
Vega, C.6
-
58
-
-
0029148566
-
Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia
-
Vargas, S., W. Hughes, A. Wakefield, and H. Oz. 1995. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J. Infect. Dis. 172:506-510.
-
(1995)
J. Infect. Dis.
, vol.172
, pp. 506-510
-
-
Vargas, S.1
Hughes, W.2
Wakefield, A.3
Oz, H.4
-
59
-
-
0028004045
-
Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats
-
Walzer, P. D., J. Foy, J. Runck, P. Steele, M. White, R. S. Klein, A. Otter, and R. J. Sundberg. 1994. Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats. Antimicrob. Agents Chemother. 38: 2572-2576.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2572-2576
-
-
Walzer, P.D.1
Foy, J.2
Runck, J.3
Steele, P.4
White, M.5
Klein, R.S.6
Otter, A.7
Sundberg, R.J.8
-
60
-
-
0022627895
-
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
-
Wharton, J. M., D. L. Coleman, C. B. Wofsy, J. M. Luce, W. Blumenfeld, W. K. Hadley, L. Ingram-Drake, P. A. Volberding, and P. C. Hopewell. 1986. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:37-44.
-
(1986)
Ann. Intern. Med.
, vol.105
, pp. 37-44
-
-
Wharton, J.M.1
Coleman, D.L.2
Wofsy, C.B.3
Luce, J.M.4
Blumenfeld, W.5
Hadley, W.K.6
Ingram-Drake, L.7
Volberding, P.A.8
Hopewell, P.C.9
-
61
-
-
0029079054
-
Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia
-
White, A., S. LaFon, M. Rogers, E. Andrews, and N. Brown. 1995. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:280-285.
-
(1995)
J. Acquired Immune Defic. Syndr. Hum. Retrovirol.
, vol.9
, pp. 280-285
-
-
White, A.1
LaFon, S.2
Rogers, M.3
Andrews, E.4
Brown, N.5
|